KND » Topics » Goodwill

This excerpt taken from the KND 10-K filed Mar 11, 2005.

Goodwill

 

In accordance with SFAS No. 142, “Goodwill and Other Intangible Assets,” the Company ceased amortizing goodwill beginning on January 1, 2002. In lieu of amortization, the Company is required to perform an impairment test for goodwill at least annually or more frequently if adverse events or changes in circumstances indicate that the asset may be impaired. The Company performs its annual impairment test at the end of each year. No impairment charge was recorded in each of the last three years in connection with the annual impairment test.

 

To the extent the Company realizes net deferred tax assets or resolves certain income tax examination contingencies related to the pre-reorganization period, goodwill recorded in connection with fresh-start accounting is reduced accordingly. In 2003, the Company reduced goodwill by $59.1 million related primarily to the recognition of such deferred tax assets. As a result of the reductions recorded in 2003, the fresh-start accounting goodwill was eliminated in full.

 

F-10


Table of Contents
Index to Financial Statements

KINDRED HEALTHCARE, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

 

NOTE 1 – ACCOUNTING POLICIES (Continued)

 

Goodwill (Continued)

 

Changes in the carrying amount of goodwill follow (in thousands):

 

     Hospital
division


    Health
services
division


    Pharmacy
division


    Total

 

Balances, January 1, 2003

   $ 55,168     $ 31,045     $ 2,046     $ 88,259  

Purchase price adjustments related to the Specialty Acquisition (as defined)

     2,301                   2,301  

Pre-emergence income tax examination resolutions

     (6,394 )     (7,598 )     (508 )     (14,500 )

Pre-emergence deferred tax valuation allowance adjustment

     (19,658 )     (23,447 )     (1,538 )     (44,643 )
    


 


 


 


Balances, December 31, 2003

     31,417                   31,417  

Pharmacy acquisition

                 705       705  

Purchase price adjustments related to the Specialty Acquisition

     (540 )                 (540 )
    


 


 


 


Balances, December 31, 2004

   $ 30,877     $     $ 705     $ 31,582  
    


 


 


 


 

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki